Potent In vitro and In vivo Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia Holly M. Horton1, Matthew J. Bernett1,...
re: Is it true that most clinical trials won't accept you if you have no symptoms. I'm grade 1 stage 4 with absolutely no symptoms. I asked my medical...
re: Betsy, Greg, Jamie Reno and I are not "selling" anything - not even false hope. But, each true story is amazing in how patients cope and handle diagnosis,...
Treatment Advances Critical In Reducing Death Rates Of Fifth-Most Common Cancer (NAPSI)-This year, the American Cancer Society estimates that more than 565,000...
Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia. Stefano Molica, Gaetano Vitelli, Giovanna...
Expression profile of Eph receptors and ephrin ligands in healthy human B lymphocytes and chronic lymphocytic leukemia B-cells. Luis M Alonso-C, Eva M A...
Now this is what I think is wonderful for every person, no matter what or if they have a disease, to keep on file. thank you very much. Jenny Lou ... From:...
[Socialized medicine shafts the patient yet again. Really want fewer cancer drugs???] Life-Extending Kidney Cancer Drug Commended For Health Benefit And ...
Doctors offer patients scant empathy in study Mon Sep 22, 2008 4:09pm EDT By Will Dunham WASHINGTON (Reuters) - During an appointment with his doctor, a man ...
Pitt research indicates new virus is culprit, not bystander, in deadly skin cancer Findings show molecular evolution of virus; reported in Proceedings of the...
Duke medical team finds genetic link between immune and nerve systems DURHAM, N.C. — Duke University Medical Center researchers have discovered genetic links...
Hi, Thank you so much for posting. What an ordeal! I need to learn more about this subject, but I don't think a port is always required; that it can depend on...
University of North Carolina Transplant guide for Patients and caregivers: http://uncsct.com/PatientManual/Patient%20Guide%20March%202004.pdf All the best, ~...
re: extending remission after Fludarabine and Rituximab chemo. I have CLL and just finished a 6 month chemo and am told that this will last two to three years....
[There is no abstract to the article, but the entire publication is online. There is a chart included in the article which I recommend (if you have nerves of...
[But this may be an important treatment for a VERY difficult disease which is very likely to kill. However, this is not something you're going to brag about at...
[Cidofovir is also used for some CMV infections.] Cidofovir Stabilizes EBV-Associated Nasopharyngeal Carcinoma By Will Boggs, MD NEW YORK (Reuters Health) Jun...
Blood First Edition Paper, prepublished online October 3, 2008; DOI 10.1182/blood-2008-02-138560. AT-101 induces apoptosis in CLL B-cells and overcomes stromal...
Greetings, This targeted agent is one of the few agents of any kind being tested in first line use for follicular lymphoma (to delay progression), and as a way...
Lenalidomide: what is the right dose in CLL? http://bloodjournal.hematologylibrary.org/cgi/content/full/111/11/5268 All the best, ~ Karl [Non-text portions of...
Guide to Novel Treatments for AML, CLL, and NHL Acute myelogenous leukemia (AML) and chronic lymphocytic leukemia (CLL) and are the two most common types of...
Greetings, Just a few years ago CML, a type of leukemia, was a devastating diagnosis. The prognosis was dire; death was nearly certain. But thanks to the...
Haematologica 2008, 10.3324/haematol.12955 Autoimmune conditions and chronic infections in chronic lymphocytic leukemia patients at diagnosis are associated...
It should be noted that Gleevic was blocked for years by the drug company Novartis, in spite of the remarkable clinical trial results Karl refers to here....
Hi Scott, I feel and appreciate your frustration. It's certainly true that if there is not a profitable way to market a drug that it will not be developed. ...
Blood, 15 October 2008, Vol. 112, No. 8, pp. 3322-3329. Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia:...
Developing An Analytic Tool To Assist In Accurately Identifying Leukemia Stem Cells 03 Oct 2008 As part of a comprehensive R&D effort to develop an analytic...
Having problems with message search?
Fill out this form to ensure your group is one of the first to be migrated to the new message search system.
